According to a recent report published by Grand View Research, Inc., the global autosamplers market is projected to attain a value of USD 1.8 billion by the year 2027, registering a compound annual growth rate (CAGR) of 6.9% over the forecast period. This anticipated growth is primarily driven by a surge in the number of research studies and the increasing application of chromatography within the pharmaceutical sector. Additionally, the growing implementation of automation technologies in laboratory settings is playing a significant role in fueling market expansion.

In modern scientific environments, laboratories have evolved into multifunctional research hubs, where various forms of testing, innovative research methodologies, and experimental advancements are performed simultaneously. With the consistent rise in the volume of test samples, there is an increasing need to process large batches of samples efficiently. As a result, demand for automated systems and instruments, such as autosamplers, is steadily increasing across different laboratory applications.

The widespread integration of autosamplers into analytical systems has proven instrumental in enhancing laboratory productivity. Analytical chemists can now generate high-quality and consistent data without the need for continuous manual intervention, allowing for more efficient use of time and resources. Autosamplers provide a number of benefits, including improved reproducibility, enhanced accuracy, and a significant reduction in human errors during the sample handling process. Moreover, these devices are designed to accommodate multiple sample vials in a single sequence, making it easier to process a variety of samples under similar analytical conditions.

In the realm of research and development, especially in specialized fields like pharmacokinetics, there is an urgent need to analyze large volumes of samples rapidly and precisely. Addressing this need, Shimadzu Corporation introduced the Nexera MP Ultra High Performance Liquid Chromatograph, which incorporates the SIL-30ACMP Multiplate Autosampler. This advanced system delivers ultra-fast injection capabilities, enabling laboratories to conduct continuous analysis of up to 2,304 samples, thereby significantly accelerating the R&D process.

Regionally, the Asia Pacific market is expected to register the highest CAGR during the forecast timeframe. This regional growth is largely attributed to the rapid expansion of the pharmaceutical and biotechnology sectors across several Asia Pacific countries. The rising demand for state-of-the-art medical devices and laboratory automation solutions in the region is acting as a key driver for the autosamplers market’s development in this part of the world.

Curious about the Autosamplers Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

FAQ for the Global Autosamplers Market

1. What is the projected size of the global autosamplers market by 2027?

The global autosamplers market is expected to reach USD 1.8 billion by 2027, expanding at a CAGR of 6.9% from 2020 to 2027.

2. What factors are driving the growth of the autosamplers market?

Key drivers include:

• Increasing number of research studies and rising demand for chromatography in the pharmaceutical industry.

• Growing usage of automation in laboratories to handle large sample volumes efficiently.

• Advancements in analytical techniques requiring high-speed and high-precision sample analysis.

3. What are the benefits of using autosamplers in laboratories?

Autosamplers offer several advantages:

• Enhanced reproducibility and high accuracy in sample analysis. 

• Minimization of human errors during sampling.

• Ability to house multiple sample vials in each sequence, facilitating the analysis of various samples under similar conditions.

• Continuous operation without the need for constant human presence, increasing laboratory productivity.

4. Which product segment dominates the autosamplers market?

The autosampler systems segment dominated the market, accounting for a revenue share of 63.6% in 2019. This segment is anticipated to register the fastest growth during the forecast period due to the increasing adoption of autosamplers for their various advantages. 

5. Which end-user segment holds the largest share in the autosamplers market?

The pharmaceutical and biotechnology companies segment dominated the market, accounting for a revenue share of 34.9% in 2019. This is attributed to the increasing R&D activities and the need for high-quality data in these industries. 

6. Which region leads the global autosamplers market?

North America held the maximum revenue share of 39.9% in 2019 and is anticipated to exhibit the fastest growth rate over the forecast period. This growth is attributed to significant investments in R&D and technological advancements in analytical techniques in the region.

Order a free sample PDF of the Autosamplers Market Intelligence Study, published by Grand View Research.